4.8 Article

Infant and Adult Inhalation Exposure to Resuspended Biological Particulate Matter

Journal

ENVIRONMENTAL SCIENCE & TECHNOLOGY
Volume 52, Issue 1, Pages 237-247

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.est.7b04183

Keywords

-

Funding

  1. Academy of Finland [296817]
  2. Centre for International Mobility (CIMO) in Finland
  3. U.S. Environmental Protection Agency Science to Achieve Results (STAR) Fellowship Program [F13D10740]
  4. Purdue University start-up funds
  5. U.S. Department of State Fulbright Program
  6. American-Scandinavian Foundation
  7. EPA [673538, F13D10740] Funding Source: Federal RePORTER
  8. Academy of Finland (AKA) [296817, 296817] Funding Source: Academy of Finland (AKA)

Ask authors/readers for more resources

Human-induced resuspension of floor dust is a dynamic process that can serve as a major indoor source of biological particulate matter (bioPM). Inhalation exposure to the microbial and allergenic content of indoor dust is associated with adverse and protective health effects. This study evaluates infant and adult inhalation exposures and respiratory tract deposited dose rates of resuspended bioPM from carpets. Chamber experiments were conducted with a robotic crawling infant and an adult performing a walking sequence. Breathing zone (BZ) size distributions of resuspended fluorescent biological aerosol particles (FBAPs), a bioPM proxy, were monitored in real-time. FBAP exposures were highly transient during periods of locomotion. Both crawling and walking delivered a significant number of resuspended FBAPs to the BZ, with concentrations ranging from 0.5 to 2 cm(-3) (mass range: similar to 50 to 600 mu g/m(3)). Infants and adults are primarily exposed to a unimodal FBAP size distribution between 2 and 6 mu m, with infants receiving greater exposures to super-10 mu m FBAPs. In just 1 min of crawling or walking, 10(3)-10(4) resuspended FBAPs can deposit in the respiratory tract, with an infant receiving much of their respiratory tract deposited dose in their lower airways. Per kg body mass, an infant will receive a nearly four times greater respiratory tract deposited dose of resuspended FBAPs compared to an adult.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available